VivoSim Labs
VIVS
46 hedge funds and large institutions have $8.23M invested in VivoSim Labs in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
12% more funds holding
Funds holding: 41 → 46 (+5)
0.07% more ownership
Funds ownership: 2.1% → 2.17% (+0.07%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
45% less capital invested
Capital invested by funds: $14.9M → $8.23M (-$6.67M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
Top Sellers
VIVS Hedge Fund Activity: Q4 2021 in Review
46 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2021, worth a combined $8.23M — down 45% from $14.9M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VIVS positions and 6 closed out — a net gain of 6 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $393K. The largest seller was ARK Investment Management, cutting an estimated $276K.
- 46 institutional investors held VivoSim Labs (VIVS) as of Q4 2021, up from 41 in Q3 2021.
- Funds reported $8.23M of VivoSim Labs stock for Q4 2021, down 45% quarter-over-quarter.
- 12 funds opened new VivoSim Labs positions in Q4 2021 and 6 closed out, a net change of +6 holders.
- The largest VivoSim Labs buyer in Q4 2021 was Renaissance Technologies, an estimated $393K added.
- The largest VivoSim Labs seller in Q4 2021 was ARK Investment Management, an estimated $276K sold.
Based on aggregated 13F filings for Q4 2021.